FDA Addresses Cell and Gene Therapy Manufacturing Challenges
Although cell and gene therapy (CGT) products that treat previously untreatable diseases are being approved, manufacturing these products can be challenging.Cell therapy manufacturing uses living cells, so stability can be an issue for both source materials and final products. Frequently the shelf life of these products is just a few hours.This presents logistical issues, including […]
